Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Aim of this study is to evaluate safety and efficacy of Iloprost in protecting coronary microcirculation during percutaneous angioplasty thanks to the action of Iloprost against vasoactive substances delivered during coronary dilatation. Iloprost efficacy will be detected by the capacity of the drug to reduce the incidence and severity of enzyme dismission after elective or urgent coronary angioplasty in patients without ST-elevation myocardial infarction (STEMI)
Critère d'inclusion
- Coronary heart disease with stable angina or non-ST elevation myocardial infarction (NSTEMI)